The registration and abstract submission systems are now closed.
Brian Bachmann, Vanderbilt University, USA
Arunava Bandyopadhaya, Massachusetts General Hospital and Harvard Medical School, USA
Tadhg Begley, Texas A&M University, USA
Carole Bewley, National Institutes of Health, USA
Matthew Bogyo, Stanford University School of Medicine, USA
Tohru Fukuyama, Nagoya University, Japan
Sylvie Garneau-Tsodikova, University of Kentucky, USA
Stephen Hanessian, Université de Montréal, Canada
Yujiro Hayashi, Tohoku University, Japan
Alexander Kornienko, Texas State University, USA
Craig Lindsley, Vanderbilt University, USA
John MacMillan, University of Texas, Southwestern Medical Center, USA
Christian Melander, North Carolina State University, USA
Rolf Müller, Helmholtz center for Infection Research, Germany
Andy Myers, Harvard University, USA
Deepak Nijhawan, University of Texas, Southwestern Medical Center, USA
Elizabeth Nolan, MIT, USA
Margaret Phillips, University of Texas, Southwestern Medical Center, USA
David Spiegel, Yale University, USA
Richard Taylor, Notre Dame University, USA
Philip Thomas, University of Texas, Southwestern Medical Center, USA
Steve Wittenberger, AbbVie Paharmaceutical Research and Development, USA
The driving force behind the organization of the ICCA meetings has been the continued need for a conference that focuses on bioactive substances derived from microogranisms and other natural sources.
We will keep with past traditions by maintaining an interdisciplinary program that will highlight research efforts in natural products isolation, structural determination, synthesis and biological evaluation. In addition, ICCA will feature new research directions and methods for drug development that have developed as a result of studying natural products and their modes of biological action.
The conference will provide an environment that will serve to promote collaboration among scientists carrying out cutting edge research in both industry and academia. These collaborations will help in the discovery, synthesis, and development of new bioactive compounds.